858 A bispecific antibody targeting CD40 and EpCAM induces superior anti-tumor effects compared to the combination of the monospecific antibodies

• Peter Ellmark,
• Karin Hägerbrand,
• Doreen Werchau,
• Anna Rosén,
• Karin Barchan,
• Adnan Deronic,
• Mattias Levin,
• Laura Von Schantz,
• Laura Varas,
• Anna Säll,
• Lill Ljug,
• Mia Thageson,
• Christina Sakellariou

Affiliations

Peter Ellmark

Aff2 grid.432080.dAlligator Bioscience AB Lund Sweden

Karin Hägerbrand

Aff1 grid.432080.dAlligator Bioscience AB Medicon Village, Scheelevägen 2 223 81 Lund Sweden

Doreen Werchau

Aff1 grid.432080.dAlligator Bioscience AB Medicon Village, Scheelevägen 2 223 81 Lund Sweden

Anna Rosén

Aff1 grid.432080.dAlligator Bioscience AB Medicon Village, Scheelevägen 2 223 81 Lund Sweden

Karin Barchan

Aff1 grid.432080.dAlligator Bioscience AB Medicon Village, Scheelevägen 2 223 81 Lund Sweden

Adnan Deronic

Aff3 grid.4514.40000000109302361Immunology GroupLund University Lund Sweden

Mattias Levin

1Alligator Bioscience AB, Lund, Sweden

Laura Von Schantz

1Alligator Bioscience AB, Lund, Sweden

Laura Varas

1Alligator Bioscience AB, Lund, Sweden

Anna Säll

1Alligator Bioscience AB, Lund, Sweden

Lill Ljug

1Alligator Bioscience AB, Lund, Sweden

Mia Thageson

1Alligator Bioscience AB, Lund, Sweden

Christina Sakellariou

2Lund University, Lund, Sweden